Literature DB >> 1859848

Liposomes for the transformation of eukaryotic cells.

P Hug1, R G Sleight.   

Abstract

Gene therapy of human disease is a method of treatment under active development. DNA-loaded liposomes exhibit great promise for use in this field. Liposome-based transfection vectors have many inherent advantages that will likely lead to their wide in vivo use. Vectors with low toxicity and a high degree of targetability can now be easily prepared. These vectors are also free of the length constraints governing retroviral vectors. In this review we discuss recent developments in the use of liposomes for transfection of eukaryotic cells.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1859848     DOI： 10.1016/0925-4439(91)90016-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


  10 in total

1.  Transfection of mouse mammary epithelial cells.

Authors:  C A Hollmann; D Medina; J S Butel
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-02       Impact factor: 2.416

2.  Analysis of apoptosis during hair follicle regression (catagen)

Authors:  G Lindner; V A Botchkarev; N V Botchkareva; G Ling; C van der Veen; R Paus
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

3.  Cationic liposomes enhance the rate of transduction by a recombinant retroviral vector in vitro and in vivo.

Authors:  C D Porter; K V Lukacs; G Box; Y Takeuchi; M K Collins
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

Review 4.  Prospects for gene therapy in sports medicine.

Authors:  T G Gerich; F H Fu; P D Robbins; C H Evans
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  1996       Impact factor: 4.342

5.  Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery.

Authors:  I van der Woude; A Wagenaar; A A Meekel; M B ter Beest; M H Ruiters; J B Engberts; D Hoekstra
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

6.  Tissue-specific expression of an anti-ras ribozyme inhibits proliferation of human malignant melanoma cells.

Authors:  Y Ohta; H Kijima; T Ohkawa; M Kashani-Sabet; K J Scanlon
Journal:  Nucleic Acids Res       Date:  1996-03-01       Impact factor: 16.971

7.  Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes.

Authors:  R Philip; E Brunette; L Kilinski; D Murugesh; M A McNally; K Ucar; J Rosenblatt; T B Okarma; J S Lebkowski
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

Review 8.  Recent trends of polymer mediated liposomal gene delivery system.

Authors:  Shyamal Kumar Kundu; Ashish Ranjan Sharma; Sang-Soo Lee; Garima Sharma; C George Priya Doss; Shin Yagihara; Do-Young Kim; Ju-Suk Nam; Chiranjib Chakraborty
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

9.  Characterization of cationic lipid DNA transfection complexes differing in susceptability to serum inhibition.

Authors:  Godwin Nchinda; Klaus Uberla; Olaf Zschörnig
Journal:  BMC Biotechnol       Date:  2002-07-12       Impact factor: 2.563

10.  Antitumor effect of diphtheria toxin A-chain gene-containing cationic liposomes conjugated with monoclonal antibody directed to tumor-associated antigen of bovine leukemia cells.

Authors:  S Watarai; M Onuma; Y Aida; H Kakidani; H Kodama; T Yasuda
Journal:  Jpn J Cancer Res       Date:  1998-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.